Approach to Bone Health in the Patient with Breast Cancer.
Yasaman MotlaghzadehJoy Y WuPublished in: The Journal of clinical endocrinology and metabolism (2024)
Treatment for breast cancer, including endocrine therapies, can contribute to bone loss and increase the risk of osteoporosis and fractures. Management of bone health in cancer patients is often coordinated between oncologists, endocrinologists, and primary care physicians. In this article we discuss the approach to screening for fracture risk among patients initiating treatments for breast cancer, and recommendations for lifestyle modifications to optimize bone health. We will review three indications for pharmacologic bone-targeted therapies: prevention of cancer treatment-induced bone loss, adjuvant therapy to reduce recurrence, and management of bone metastases.
Keyphrases
- bone loss
- primary care
- public health
- healthcare
- bone mineral density
- mental health
- health information
- metabolic syndrome
- postmenopausal women
- cardiovascular disease
- physical activity
- soft tissue
- type diabetes
- health promotion
- weight loss
- body composition
- drug induced
- clinical practice
- young adults
- human health
- free survival
- smoking cessation